<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03944382</url>
  </required_header>
  <id_info>
    <org_study_id>Fibri_retro</org_study_id>
    <nct_id>NCT03944382</nct_id>
  </id_info>
  <brief_title>What Are the Effects of Fibrinogen Concentrate Administration on Biological Parameters</brief_title>
  <acronym>Fibri_retro</acronym>
  <official_title>What Are the Effects of Fibrinogen Concentrate Administration on Biological Parameters</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Erasme University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Erasme University Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      the fibrinogen concentrate are given since 50 years with the dose of 2g for a
      afibrinogenemia. But this dose has been fixed 40 years ago and from now nobody discuss this
      quantity. Through this retrospective study the investigators tried to explore the evolution
      of blood test after a prescription of fibrinogen concentrate
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      the fibrinogen concentrate are given since 50 years with the dose of 2g for a
      afibrinogenemia. But this dose has been fixed 40 years ago and from now nobody discuss this
      quantity. Through this retrospective study the investigators tried to explore the evolution
      of blood test after a prescription of fibrinogen concentrate.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">January 1, 2016</start_date>
  <completion_date type="Actual">December 31, 2017</completion_date>
  <primary_completion_date type="Actual">December 31, 2017</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Evolution of fibrinogen</measure>
    <time_frame>one day</time_frame>
    <description>Fibrinogen was measured before and after a fibrinogen factor transfusion. It will be used to calculate the delta (after - before) and mesure the efficiency of a transfusion</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Evolution of FIBTEM A5®</measure>
    <time_frame>one day</time_frame>
    <description>FIBTEM A5® was measured before and after a fibrinogen factor transfusion. It will be used to calculate the delta (after - before) and mesure the efficiency of a transfusion</description>
  </primary_outcome>
  <enrollment type="Actual">125</enrollment>
  <condition>Hemorrhage</condition>
  <eligibility>
    <study_pop>
      <textblock>
        all patient who received fibrinogen concentrate
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  all patient who received fibrinogen concentrate

        Exclusion Criteria:

          -  none
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Olivier DURANTEAU, Trainee</last_name>
    <role>Principal Investigator</role>
    <affiliation>Erasme UH</affiliation>
  </overall_official>
  <verification_date>February 2020</verification_date>
  <study_first_submitted>February 25, 2019</study_first_submitted>
  <study_first_submitted_qc>May 8, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">May 9, 2019</study_first_posted>
  <last_update_submitted>February 26, 2020</last_update_submitted>
  <last_update_submitted_qc>February 26, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">February 28, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hemorrhage</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

